Brief: Xbrane Biopharma Q3 EBITDA SEK -6.6 Million
30/10/2026 07:01
BRIEF-Xbrane Biopharma Q3 EBITDA SEK -6.6 Million Oct 30 (Reuters) - Xbrane Biopharma Q3 revenue SEK 54.8 million.
- Q3 net income SEK -11.7 million
- Q3 EPS SEK -0.57
XBRANE — Xbrane Biopharma AB News Story
0.000.00%
Last trade - 00:00- SEK235.93m
- SEK262.45m
- SEK152.35m